Biotech company developing drug to extend lifespan of large dogs
CBSN
All dogs may go to heaven, but one biotech startup is looking to keep labradors and other bigger canines on Earth longer.
A drug to extend the lifespan of large dogs — who live about half as long as smaller breeds — could be on the market in coming years, according to Loyal, a San Francisco biotech company developing longevity treatments for canines.
The Food and Drug Administration Center for Veterinary Medicine has found a reasonable expectation of effectiveness for the drug, codenamed LOY-001, Loyal announced Tuesday in a news release, a big step toward its full approval. The development is "a first for any longevity drug, and is a big step towards accelerating the path for canines, and ultimately humans," stated Vinod Khosla, founder of Khosla Ventures, an investor in Loyal.

The peace and tranquility of Muir Woods, just north of San Francisco – home to 500+ acres of old-growth redwoods – make it just about the last place you'd expect to find a fight brewing. "The fact that they're taking down whole groups of signs about climate change and our nation's history is disappointing, and embarrassing," said retired U.S. Park Ranger Lucy Scott In:

We share our planet with maybe 10 million species of plants, animals, birds, fish, fungi and bugs. And to help identify them, millions of people are using a free phone app. "Currently we have about six million people using the platform every month," said Scott Loarie, the executive director of iNaturalist, a nonprofit.

At ski resorts across the West this winter, viral images showed chairlifts idling over brown terrain in places normally renowned for their frosty appeal. Iconic mountain towns like Aspen, Colorado, and Park City, Utah, were seen with shockingly bare slopes, as the region endured a historic snow drought that experts warn could bring water shortages and wildfires in the months ahead. In:










